Data / Form D filings / Hinge Bio, Inc.
Hinge Bio, Inc.: Form D filings
Hinge Bio, Inc., a biotechnology company in Burlingame, CA, filed 6 Form D notices with the SEC between 2020 and 2025. The latest, on January 15, 2025, reports $30.6 million sold of a $40.8 million offering to 82 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 863 MITTEN ROAD, SUITE 100L, Burlingame, CA, 94010
- Phone
- (650) 488-7070
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1804959
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | New notice | $40,800,009 | $30,596,388 | $10,203,621 | 82 | Dec 31, 2024 | sec.gov |
| Feb 1, 2021 | Amendment | $18,000,000 | $18,000,000 | 77 | Dec 18, 2020 | sec.gov | |
| Jan 14, 2021 | Amendment | $18,000,000 | $12,732,000 | $5,268,000 | 67 | Dec 18, 2020 | sec.gov |
| Jan 7, 2021 | New notice | $18,000,000 | $10,287,000 | $7,713,000 | 47 | Dec 18, 2020 | sec.gov |
| Apr 28, 2020 | Amendment | $19,042,038 | $18,191,739 | $850,299 | 100 | Feb 11, 2020 | sec.gov |
| Feb 27, 2020 | New notice | $19,042,038 | $18,191,739 | $850,299 | 100 | Feb 11, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John Misha Petkevich | Director | |
| Alex E. Silverstein | Director | |
| Malcolm E. Gefter | Director | |
| Jeffrey Misha Long-McGie | Director | |
| Harold E. Selick, PhD | Executive Officer, Director | |
| Miriam Misha Siekevitz | Executive Officer |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Jan 13, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Hinge Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.